Episode Details
Back to Episodes
CC Pharm | Nitroprusside
Season 7
Published 6 days, 5 hours ago
Description
Sodium nitroprusside is an ultra-potent, direct-acting peripheral vasodilator characterized by rapid hemodynamic action and highly toxic metabolites. This 80/20 summary distills its essential clinical, pharmacological, and nursing guidelines:
1. Mechanism & Hemodynamic Effects
- Mechanism: Direct action on arterial and venous smooth muscle; myocardial contractility is unaffected.
- Hypertension: Reduces afterload and causes venous pooling, decreasing arteriolar resistance.
- Heart Failure: Improves left ventricular performance, increasing cardiac index, cardiac output, and stroke volume while slowing heart rate.
2. Dosing & Clinical Administration
- Onset & Duration: Rapid onset (1-2 mins); effects persist for 1-10 mins after discontinuation.
- Titration: Confirm drug effect for 5 minutes before titrating to a higher dose.
- Dosing (Adults):
- Hypertensive Emergency: Start 0.3-0.5 mcg/kg/min; titrate by 0.5 mcg/kg/min every 5 mins. Max: 10 mcg/kg/min for 10 mins.
- Acute Heart Failure: Start 0.1-0.3 mcg/kg/min. Max: 10 mcg/kg/min (doses >400 mcg/min have no added benefit).
- Mitral Regurgitation: Start 15 mcg/min, titrate every 2 mins to reduce mean arterial pressure by 10-20 mmHg.
- Preparation & Administration:
- Dilute 50 mg in 250–1000 mL of 5% Dextrose (D5W). Never give direct IV injection.
- Solution is clear, colorless to red/brown; discard if blue, green, or bright red.
- Protect from light during administration with an opaque sleeve.
- Do not run other drugs in the same solution.
3. Boxed Warning: Cyanide & Thiocyanate Toxicity
- Cyanide Toxicity: Metabolism produces dose-related cyanide.
- Doses >2 mcg/kg/min exceed normal clearance. Buffering is exceeded in <1 hour at the max 10 mcg/kg/min rate.
- Action: Discontinue and consider sodium nitrite and sodium thiosulfate.
- Thiocyanate Toxicity: Cyanide converts to thiocyanate via mitochondrial rhodanase (renal half-life: 3 days).
- Life-threatening at 200 mg/L. Monitor plasma levels if cumulative doses exceed 7 mg/kg/day.
- Organ Impairment Risk:
- Hepatic disease: High susceptibility to cyanide toxicity.
- Renal Impairment: eGFR <30: limit mean infusion to <3 mcg/kg/min (Anuria: limit to 1 mcg/kg/min).
4. Nursing Interventions
- Monitoring: Mandatory continuous blood pressure monitoring, preferably via an intraarterial pressure sensor. Monitor urine output in heart failure.
- Safety: Use a volumetric infusion pump. Watch for hypotension, methemoglobinemia, bradycardia, or metabolic acidosis.